0 Items
Select Page

Adenovirus

Having been founded by Adenovirus specialists, The Native Antigen Company offers in-depth expertise both in catalogue reagents and customised Adenovirus preparations.

We supply purified Adenovirus antigens, alongside monoclonal antibodies to Adenovirus hexon protein. On request we can also undertake custom preparation of Adenoviruses from a number of viral strains, including constructs expressing GFP, LUC and other recombinant proteins.

Adenovirus Background

Human Adenoviruses (HAdV) are non-enveloped, non-segmented, double stranded DNA viruses, belonging to the genus Mastadenovirus within the Adenoviridae family. Human Adenoviruses have been further classified into seven species groups, A- G. Since the discovery of Adenovirus in human adenoid tissue in 1953, more than 50 human serotypes and 70 genotypes have been identified (Cook, J).

Human Adenoviruses are globally widespread and ubiquitous in the environment. HAdV can persist in the environment and is resistant to most household disinfectants. Transmission of HAdV occurs primarily via the faecal-oral route, with contaminated water and food being a major source of infection. HAdV may also be spread through contact with contaminated surfaces and through aerosol droplets from an infected individual.

Human Adenoviruses most commonly cause respiratory disease, but some serotypes can cause gastrointestinal disease, conjunctivitis and cystitis. The clinical disease caused by HAdV infection varies depending on the HAdV type. In immunocompromised patients, HAdV infection can cause severe clinical symptoms that may lead to respiratory failure, neurological disease and death.

Currently there is no specific treatment for HAdV infection, which is mild and self-limiting in most cases, and licensed vaccines are not available for prophylactic treatment of the general public (CDC).

References

  1. Cook J, Radke J. (2017). Mechanisms of pathogenesis of emerging adenoviruses. F1000Res. Jan 30;6:90. PMID: 28184296
  2. Centers for Disease Control and Prevention: Adenoviruses

Adenovirus Antigens

Our range of adenovirus antigens includes a highly purified preparation of Ad40 particles, alongside purified hexon protein from both Ad5 and Ad40.

The adenovirus hexon protein is a major component of the adenovirus capsid, which readily forms trimers and then further self-assembles into capsomeres of 240 hexons.

 

Adenovirus Antibodies

We offer a pair of monoclonal antibodies that are specific to the hexon protein adenovirus antigen. Hexon protein is the largest and most abundant structural protein in the adenovirus capsid. These antibodies are suitable for use in ELISA and as pairs in immunoassay development.

Both antibodies recognise hexon protein from all strains of adenovirus that have been tested, including strains 2, 3, 4, 5, 15, 31, 40 and 41.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Overcoming Zika-Dengue cross-reactivity: the highly specific immunoassays your lab needs

In the global battle against Zika virus, serological cross-reactivity with Dengue is a major challenge for academics, epidemiologists and pharmaceutical companies alike. Novel immunoassays can now overcome this problem and could prove a real game-changer in Zika...

The Right Tools for Rubella

Rubella remains a significant pathogen worldwide, with 100,000 cases of congenital rubella syndrome estimated to occur every year. Vaccines to rubella are highly safe and have effectively eliminated endemic infection in many developed countries, yet inadequate...

Visualising viral infection with immunofluorescence microscopy

Following the latest immunofluoresence data for our Zika and Dengue antibodies, we’ve invited VRS to write a short blog one of their areas of expertise: The applications of immunofluorescence microscopy in studying viruses.   A lot of what we know about biology...

Challenges to Effective Yellow Fever Diagnostics

Yellow fever is a haemorrhagic viral disease, transmitted by infected mosquitos in Africa and South America. While an effective vaccine is available, inadequate vaccination of endemic areas has made diagnostics a necessity to controlling ongoing outbreaks. However,...

Five Methods You Can Use to Overcome Zika-Dengue Cross-Reactivity

Cross-reactivity between the Zika and Dengue viruses in serological assays is one of the biggest challenges faced by the epidemiologists, academics and pharmaceutical companies trying to control the Zika epidemic, as it brings the quality and reliability of diagnostic...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

1 + 15 =

Live Customer Feedback